“Cumulative” and “compounding” are two different machines, and sponsors mix them up constantly. Cumulative means an unpaid preferred return carries forward to the next year, dollar-for-dollar. Compounding means that same unpaid amount goes into a pool that earns its own additional return.
That one distinction changes how much cash the investor is owed before the sponsor sees a dime of promote. It also changes what your Operating Agreement has to say. If the document does not spell out which machine you are running, you have a dispute waiting to happen.
Neither one is interest, and neither one is a guaranteed payment. Both are target distributions paid out of available cash under the terms of the governing agreement. Keep that framing in mind, because it matters later.
Defining the Cumulative Mechanism
A cumulative preferred return carries any shortfall forward without growing it. If the target distribution for the year does not get paid in full, the unpaid piece simply rolls into next year and waits its turn.
The Unreturned Capital Contribution does not change. That base stays the same. The only thing you track is the outstanding unpaid target distribution sitting in line to be paid.
This is standard in a lot of syndications, and for good reason. It protects the investor’s expected yield when the asset has a temporary lag – a lease-up delay, a soft quarter, a repositioning period. The investor still gets made whole eventually.
What the cumulative structure does not do is charge the sponsor extra for the delay. The shortfall waits. It does not earn anything on itself while it waits. A $4,000 shortfall is still a $4,000 shortfall next year.
Defining the Compounding Mechanism
A compounding preferred return takes the unpaid shortfall and lets it earn the target return too. The unpaid amount goes into what I’ll call the Unpaid Preference Pool, and that pool accrues the same preferred rate the original capital does.
Under this model, you have two earning engines instead of one. The original capital base earns the preferred return, and the accrued shortfall earns it as well. The number the investor is owed grows faster every year the deal falls behind.
Here is where sponsors get into trouble. They say “cumulative” in the pitch deck and the term sheet when they actually mean “compounding.” The words sound close enough that nobody catches it until the money moves.
That mistake is not cosmetic. If your model assumes the shortfall compounds but your Operating Agreement only describes a flat carryforward, your underwriting and your legal documents are describing two different deals. One of them is wrong, and the document wins.
Why You Must Never Call Preferred Equity “Interest”
Preferred equity is not interest, and calling it that invites a debt characterization. A debt characterization can turn your target distribution into something you did not intend: a guaranteed obligation. That is a tax problem, a securities problem, and a disclosure problem all at once.
The Danger of “Simple” and “Compound” Interest Labels
Financial software and inexperienced sponsors love the words “simple interest” and “compound interest.” They describe a cumulative preferred return as “simple interest” and a compounding preferred return as “compound interest” because the math looks the same.
The math may look the same. The legal characterization is not.
Preferred equity is a target distribution paid out of available cash flow. If the cash is not there, the distribution does not get paid. That is the whole point of equity – the investor shares in the risk that the deal does not perform.
Interest is different. Interest is what a borrower owes a lender whether or not the deal performs. It is a fixed obligation, and it gets paid before equity sees anything.
When you use interest language to describe an equity return, you blur that line. And regulators and the IRS look at substance, not labels – so the danger is that they take you at your word.
The IRS can treat the position as debt and tax it accordingly, which changes the deductibility, the character of the payments, and the return-of-capital analysis. The SEC and state regulators can look at the same language and argue you actually sold an unregistered promissory note rather than a security interest issued under Regulation D.
There is also an anti-fraud angle. If your documents describe an equity return using guaranteed-payment language, you have implied a guarantee that does not exist. That is exactly the kind of gap between what you said and what you meant that turns into an investor claim later.
The Proper Legal Vocabulary
Use equity words for an equity instrument. “Target distribution,” “unpaid preference accrual,” and “carryforward amount” all describe what is actually happening without implying a debt.
The unpaid amount is not “interest owed.” It is a preference that accrues and sits in line to be paid when cash flow allows.
Clean up your marketing collateral too. A pitch deck that says “8% simple interest” undermines an Operating Agreement that carefully defines a target distribution. The plaintiff’s lawyer reads both, and they will quote whichever one helps their investor.
The document and the deck have to speak the same language. If one says equity and the other says interest, you have created the discrepancy for someone else to exploit.
The Math: A Three-Year $100,000 Example
The difference between cumulative and compounding is easy to describe but easy to underestimate. On a $100,000 investment with an 8% preferred return, a $4,000 Year 1 shortfall stays a $4,000 problem under a cumulative structure. Under a compounding structure, that same $4,000 grows to $4,320 by Year 2, and it keeps growing every year it goes unpaid.
Here is the scenario, worked out year by year.
Setting Up the Baseline Scenario
An investor contributes $100,000 to the deal. The Operating Agreement promises an 8% preferred return, so the target distribution in a normal year is $8,000.
Year 1 comes in soft. The asset only produces $4,000 of available cash flow, so the investor receives $4,000 and the other $4,000 of the target goes unpaid.
That $4,000 is not a debt. It is an unpaid preference, tracked so it can be caught up later when cash flow recovers. What happens to it next is entirely a function of how the Operating Agreement defines it.
Calculating the Cumulative Path (Year 2 Catch-Up)
Under a cumulative structure, the $4,000 shortfall simply carries forward at face value. It waits in line.
In Year 2, the investor’s target is the normal 8% on the $100,000 base, which is $8,000, plus the $4,000 that carried over from Year 1. To clear the hurdle in Year 2, the deal needs to distribute $12,000.
Notice what did not happen. The $4,000 did not grow. It did not earn anything on itself. It moved to the front of the distribution waterfall and sat there until the cash showed up to pay it.
The unpaid preference is a flat number. The Unreturned Capital Contribution stayed at $100,000, and the shortfall stayed at $4,000.
Calculating the Compounding Path (Year 2 Catch-Up)
Under a compounding structure, the $4,000 shortfall does not just wait. It earns the preferred rate on itself.
In Year 2, the investor’s target is the normal $8,000 on the base, plus the $4,000 carryforward, plus 8% on that unpaid $4,000, which is $320. To clear the hurdle in Year 2, the deal needs to distribute $12,320.
So the entire practical difference in Year 2 is $320. On its own, $320 sounds like a rounding error.
It is not a rounding error over time. The unpaid preference compounds on a growing base, so the gap widens every year the asset stays behind. If the property takes three to five years to stabilize, that small $320 divergence stacks on itself and the compounding version pulls meaningfully ahead of the cumulative version.
Calculating the Year 3 Snowball (Zero Cash Flow Scenario)
Assume Year 2 also comes in at zero cash flow. Nothing gets paid to the investor at all. This is where the two structures stop looking similar and start producing genuinely different numbers.
Under the cumulative structure, the Year 2 target was $12,000 ($8,000 normal plus the $4,000 carried from Year 1). None of it gets paid, so the full $12,000 carries forward to Year 3 at face value. It does not grow while it waits. In Year 3, the investor’s target is the normal $8,000 plus the flat $12,000 carryforward, for a total of $20,000.
Under the compounding structure, the Year 2 target was $12,320 ($8,000 normal, plus $4,000 carried, plus $320 of accrued return on that $4,000). None of it gets paid either, so the entire $12,320 rolls into the Unpaid Preference Pool and starts earning the 8% rate on itself. In Year 3, that pool accrues another $985.60 ($12,320 x 8%). Add the normal $8,000 target for Year 3, and the investor is now owed $21,305.60.
Line them up and the snowball is obvious. Cumulative: $20,000. Compounding: $21,305.60. The gap started at $320 in Year 2. By Year 3 it is $1,305.60, and it did not take a big assumption to get there – just one more soft year.
That is the mechanism sponsors underestimate. The compounding pool does not add a fixed increment each year. It adds a percentage of an already-growing number, so the gap accelerates the longer the asset stays behind. A deal that takes three or four years to stabilize can turn a $320 rounding error into a five-figure difference in what the GP has to clear before touching the promote.
The math itself is not complicated. What matters is that the two paths produce genuinely different payout obligations, and the only thing that decides which path applies is the language in your governing document. If the document does not say the unpaid preference earns a return on itself, it does not compound – no matter what the marketing deck implied.
The Premature Liquidation Trap for the GP Promote
The GP promote is the sponsor’s own economics, and a compounding preferred return attacks it directly. The sponsor cannot touch the promote until the entire accumulated preference is paid off, and the larger that shortfall grows, the harder it becomes for the General Partner to ever get paid on the upside they created.
The Accumulated Deficit Bottleneck
In a standard distribution waterfall, the Limited Partner’s preferred return sits ahead of the GP promote. The GP receives zero on their split until the investor preference is fully caught up.
That is fine when the asset performs. It becomes a problem when it does not.
When the venture needs unexpected capital, or takes longer to stabilize than the model assumed, the shortfall keeps building. Under a compounding structure, that shortfall earns its own return, so the amount the GP must clear before seeing a dollar of promote grows faster every period.
Generic advice treats this as purely an investor-protection feature, and it is. But it ignores the operational reality on the sponsor’s side.
A GP working an asset for zero current cash flow loses flexibility. They still have to manage the deal, fund the operations, and answer to investors – all while the number they need to clear keeps climbing. That is not a comfortable position to operate from, and it is not one you want to draft yourself into by accident.
The Pressure to Sell Sub-Optimally
As the compounding deficit grows, it creates a structural incentive for the GP to exit early at a price that is not the best price. Call it the premature liquidation trap.
The logic is simple. The longer the sponsor holds, the more the compounding preference accrues, and the further away the promote drifts. At some point the GP starts looking for any exit that clears the deficit, rather than the exit that maximizes value.
That hurts everyone. Selling early to escape the payout block usually means leaving appreciation on the table – appreciation that would have gone to the Limited Partner first and the General Partner second.
So a term that looks like pure investor protection can end up producing a worse outcome for the investor, because it pushed the sponsor to sell before the asset was done working.
The point is not that compounding is wrong. The point is that you have to understand what it does to the sponsor’s incentives before you agree to it, because the structure will drive behavior whether you intended it to or not.
The Operating Agreement Governs the Math, Not the Spreadsheet
When your financial model and your legal documents disagree, the legal documents win. Courts and institutional investors read the text of the Operating Agreement or the Limited Partnership Agreement. They do not open your Excel file to figure out what you meant.
So if your document is ambiguous about compounding, your underwriting will not save you. The math you get is the math the document describes, not the math you assumed.
Why Spreadsheets Do Not Have Legal Authority
Underwriting software runs whatever formula you build. Distributions get paid based on how the terms are defined in the governing agreement.
Those are two different things. The spreadsheet is a prediction. The Operating Agreement is the instruction.
Here is where sponsors get hurt. The pitch deck and the model assume the unpaid preference compounds, but the Operating Agreement only defines a flat, cumulative carryforward. Now you have promised investors 8% on the shortfall, and your own document does not authorize you to pay it.
That is a discrepancy you cannot fix after the fact without an amendment and a very uncomfortable conversation. In the earlier example, that is the difference between owing $12,000 and owing $12,320 in Year 2, and the gap only widens the longer the asset takes to stabilize.
Drafting for Structural Clarity
The document has to say, in plain terms, whether an unpaid preference simply carries forward or whether it accrues an additional target return on itself. One sentence decides which of the two structures you are actually running.
Do not leave it to inference. “Cumulative” alone does not tell a court whether you meant compounding, and a reader who paid for the compounding version will read it their way.
A precise operating agreement and LPA legal package is the only thing that makes the payout math match your intent. That is what preserves the promote, and it is what keeps a Year 1 shortfall from becoming a Year 4 dispute.
Tilden Moschetti, Esq., is a highly sought-after syndication attorney with nearly two decades of experience. His clientele ranges from real estate developers and startups to established businesses and private equity funds. Tilden’s expertise in syndication law comes not only from his knowledge of syndication and securities law but from real, hands-on experience as an active syndicator himself in every real estate product type and nearly all markets in the US. His knowledge and experience set him apart and established him as the Reg D legal services leader.